fluorodopa f 18 has been researched along with Brain Neoplasms in 58 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (1.72) | 18.2507 |
2000's | 8 (13.79) | 29.6817 |
2010's | 40 (68.97) | 24.3611 |
2020's | 9 (15.52) | 2.80 |
Authors | Studies |
---|---|
Breen, WG; Brinkmann, DH; Brown, PD; Giri, S; Hunt, CH; Jacobson, SB; Jones, JE; Kizilbash, SH; Laack, NN; Mahajan, A; Pafundi, DH; Routman, DM; Ruff, MW; Uhm, JH; Youland, RS | 1 |
Higgins, GS; McGowan, DR; Plaha, P; Roach, JR | 1 |
Bund, C; Cebula, H; Chibbaro, S; Lefebvre, F; Lhermitte, B; Namer, IJ; Pin, Y; Proust, F; Todeschi, J | 1 |
Bertaux, M; Bielle, F; Choquet, S; Garcilazo, Y; Kas, A; Mokhtari, K; Ollivier, M; Rozenblum, L | 1 |
Bozzao, A; Carideo, L; Cicone, F; Minniti, G; Scaringi, C; Scopinaro, F; Villani, V | 1 |
Brinkmann, DH; Herman, MG; Hunt, CH; Kemp, BJ; Laack, NN; Lowe, V; Pafundi, DH; Qian, J | 1 |
Albert, NL; Castello, A; Galldiks, N; Girard, A; Guedj, E; Lopci, E; Verger, A; Zaragori, T | 1 |
Cloughesy, TF; Ellingson, BM; Hagiwara, A; Lai, A; Liau, LM; Nghiemphu, PL; Oughourlian, TC; Raymond, C; Salamon, N; Tatekawa, H; Wang, C; Yao, J | 1 |
Capelle, L; Itti, E; Kauv, P; Louarn, N; Mokhtari, K | 1 |
Anderson, SK; Brinkmann, D; Brown, P; Hunt, C; Kabat, B; Kaufmann, T; Kemp, B; Kizilbash, S; Laack, NN; Lowe, V; Pafundi, D; Ruff, M; Sarkaria, J; Seaberg, M; Uhm, J; Vogen, D; Wan Chan Tseung, HS; Yan, E; Zakhary, M; Zhang, Y | 1 |
Blazak, J; Condon, L | 1 |
Carideo, L; Cicone, F; Mamede, M; Minniti, G; Russo, I; Scaringi, C; Scopinaro, F | 1 |
Brinkmann, DH; Giannini, C; Hunt, CH; Kemp, BJ; Laack, NN; Lowe, VJ; Morris, JM; Pafundi, DH; Parney, IF; Youland, RS | 1 |
Bottoni, G; Mancardi, MM; Morana, G; Piccardo, A; Verrico, A | 1 |
Gao, L; Liang, F; Tao, L; Weng, J; Xu, W; Yu, J; Zhang, J; Zheng, J | 1 |
Arcella, A; Carideo, L; Cicone, F; Giangaspero, F; Minniti, G; Scaringi, C; Scopinaro, F | 1 |
Bellu, L; Bertin, D; Caccese, M; Cuppari, L; Evangelista, L; Lombardi, G; Reccia, P; Zagonel, V | 1 |
Calabria, F; Chiaravalloti, A; Cimini, A; Di Giorgio, E; Esposito, V; Schillaci, O; Ursini, F; Zinzi, M | 1 |
Brinkmann, DH; Giannini, C; Grams, MP; Hoover, JM; Hu, LS; Kemp, BJ; Laack, NN; Lowe, VJ; Morris, JM; Pafundi, DH; Parney, IF; Sarkaria, JN; Youland, RS | 1 |
Bal, C; Bandopadhyaya, GP; Gupta, DK; Karunanithi, S; Khangembam, BC; Kumar, A; Kumar, R; Malhotra, A; Sharma, P | 1 |
Bal, C; Bandopadhyaya, GP; Gupta, DK; Karunanithi, S; Kumar, A; Malhotra, A; Sharma, P; Singla, S | 1 |
Bal, C; Bandopadhyaya, GP; Goenka, A; Gupta, DK; Karunanithi, S; Khangembam, BC; Kumar, A; Kumar, R; Malhotra, A; Sharma, P | 1 |
Benard, F; Chan, EK; Cheung, A; Hsu, F; Kosztyla, R; Ma, R; Moiseenko, V; Nichol, A; Wilson, D; Zhang, S | 1 |
Allen-Auerbach, M; Chen, W; Czernin, J; DeSalles, AA; Lizarraga, KJ; Phelps, ME; Yong, WH | 1 |
Bal, C; Ballal, S; Gupta, DK; Karunanithi, S; Khangembam, BC; Kumar, A; Kumar, R; Sharma, P | 1 |
Afshar-Oromieh, A; Combs, SE; Debus, J; Giesel, FL; Haberkorn, U; Kratochwil, C; Leotta, K; Rieken, S | 1 |
Cloughesy, TF; Dahlbom, M; Huang, SC; Phelps, ME; Schiepers, C; Wardak, M | 1 |
Cabria, M; Cama, A; Garrè, ML; Milanaccio, C; Morana, G; Nozza, P; Piccardo, A; Puntoni, M; Rossi, A; Zefiro, D | 1 |
Chen, W; Cloughesy, TF; Czernin, J; Elashoff, D; Ellingson, BM; Geist, C; Grogan, T; Phelps, ME; Pope, WB; Schwarzenberg, J; Silverman, DH | 1 |
Chen, W; De Salles, AA; Lizarraga, KJ | 1 |
Bluemel, C; Buck, AK; Czernin, J; Ernestus, RI; Herrmann, K; Homola, GA; Kessler, AF; Lapa, C; Linsenmann, T; Löhr, M; Monoranu, CM; Samnick, S | 1 |
Bozzao, A; Cicone, F; Maurizi Enrici, R; Minniti, G; Papa, A; Romano, A; Scaringi, C; Scopinaro, F; Tavanti, F | 1 |
Chen, W; Cloughesy, TF; Czernin, J; Ellingson, BM; Harris, RJ; Karavaeva, E; Lai, A; Leu, K; Liau, LM; Nghiemphu, PL; Pope, WB; Shabihkhani, M; Yong, WH | 1 |
Carapella, C; Chiaravalloti, A; Di Pietro, B; Di Russo, C; Fiorentini, A; Floris, R; Pace, A; Palumbo, B; Schillaci, O; Villani, V | 1 |
Bozzao, A; Cicone, F; Filss, CP; Galldiks, N; Langen, KJ; Minniti, G; Papa, A; Rossi-Espagnet, C; Scaringi, C; Scopinaro, F; Shah, NJ | 1 |
Garrè, ML; Morana, G; Nobili, F; Piccardo, A; Rossi, A | 1 |
Blonski, M; Janvier, L; Karcher, G; Morel, O; Olivier, P; Taillandier, L; Verger, A; Vignaud, JM | 1 |
de Labriolle-Vaylet, C; Jehanno, N; Michon, J; Montravers, F; Wartski, M | 1 |
Garrè, ML; Lopci, E; Massollo, M; Morana, G; Naseri, M; Piccardo, A; Puntoni, M; Rossi, A; Severino, M; Tortora, D | 1 |
Bozzao, A; Cicone, F; Mancuso, V; Minniti, G; Napolitano, A; Romano, A; Rossi Espagnet, MC; Scaringi, C | 1 |
Bund, C; Chenard, MP; Heimburger, C; Imperiale, A; Kremer, S; Lefebvre, F; Lhermitte, B; Namer, IJ; Proust, F | 1 |
Arbizu, J; Galldiks, N; Langen, KJ; Law, I; Pope, WB | 1 |
Bialecki, E; Chinot, O; Colin, C; Figarella-Branger, D; Guedj, E; Metellus, P; Sala, Q; Taieb, D; Verger, A | 1 |
Chen, W; Cloughesy, T; Czernin, J; Freitas, B; Ledezma, CJ; Pope, W; Sai, V | 1 |
Fischman, AJ | 1 |
D'Souza, M; Datta, A; Garg, G; Grover, RK; Jaimini, A; Kumar, N; Mishra, AK; Mondal, A; Panwar, P; Sharma, R; Singh, D; Tripathi, M; Varshney, R | 1 |
Bourgeat, P; Coulthard, A; Crozier, S; Daglish, M; Dowson, N; Fay, M; MacFarlane, D; Rose, S; Salvado, O; Smith, J; Thomas, P; Winter, C | 1 |
Cloughesy, T; Czernin, J; Fueger, B; Lai, A; Nghiemphu, P; Phelps, ME; Satyamurthy, N; Wagle, N; Walter, F; Walter, MA | 1 |
Calabria, F; Chiaravalloti, A; Di Pietro, B; Grasso, C; Schillaci, O | 1 |
Brinkmann, DH; Giannini, C; Kitange, GJ; Laack, NN; Lowe, VJ; Pafundi, DH; Parney, IF; Peterson, TE; Pokorny, JL; Ramiscal, JA; Sarkaria, JN; Youland, RS | 1 |
De Sanctis, V; Di Stefano, D; Enrici, RM; Esposito, V; Falco, T; Lanzetta, G; Minniti, G; Scaringi, C | 1 |
Buvat, I; Capelle, L; Dulou, R; Dutertre, G; Foehrenbach, H; Gontier, E; Guillevin, R; Lahutte, M; Nioche, C; Soret, M | 1 |
Asenbaum, S; Becherer, A; Czech, T; Henk, C; Karanikas, G; Kletter, K; Marosi, C; Szabó, M; Wadsak, W; Wunderbaldinger, P; Zettinig, G | 1 |
Chen, W; Cloughesy, T; Czernin, J; Delaloye, S; Kamdar, N; Pope, W; Satyamurthy, N; Schiepers, C; Silverman, DH | 1 |
Gault, N; Grahek, D; Gutman, F; Kerrou, K; Montravers, F; Schlienger, M; Talbot, JN; Touboul, E | 1 |
Chen, W; Cloughesy, T; Dahlbom, M; Huang, SC; Schiepers, C | 1 |
Chen, W; Seibyl, JP; Silverman, DH | 1 |
Heiss, WD; Herholz, K; Lanfermann, H; Pietrzyk, U; Thiel, A; Wagner, R; Wienhard, K | 1 |
8 review(s) available for fluorodopa f 18 and Brain Neoplasms
Article | Year |
---|---|
The role of [
Topics: Adult; Brain Neoplasms; Glioma; Humans; Magnetic Resonance Imaging; Neoplasm Grading; Positron-Emission Tomography; Quality of Life | 2022 |
Accuracy of
Topics: Brain Neoplasms; Diagnosis, Differential; Dihydroxyphenylalanine; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiation Injuries; Retrospective Studies; Tyrosine | 2018 |
Comparison Between 18F-Dopa and 18F-Fet PET/CT in Patients with Suspicious Recurrent High Grade Glioma: A Literature Review and Our Experience.
Topics: Brain Neoplasms; Dihydroxyphenylalanine; Glioma; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tyrosine | 2019 |
The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy.
Topics: Amino Acids; Brain Neoplasms; Dihydroxyphenylalanine; Humans; Methionine; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2017 |
PET imaging of brain tumors.
Topics: Biopsy; Brain; Brain Neoplasms; Cell Proliferation; Diagnostic Imaging; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Lipids; Medical Oncology; Methionine; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2008 |
Molecular imaging of brain tumors with 18F-DOPA PET and PET/CT.
Topics: Brain Neoplasms; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
[PET and malignant cerebral tumors].
Topics: Brain Neoplasms; Choline; Dideoxynucleosides; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Glioma; Humans; Methionine; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
3,4-dihydroxy-6-[18f]-fluoro-L-phenylalanine positron emission tomography in patients with central motor disorders and in evaluation of brain and other tumors.
Topics: Adrenal Gland Neoplasms; Amino Acids; Brain Neoplasms; Caudate Nucleus; Dihydroxyphenylalanine; Fluorine Radioisotopes; Glioma; Humans; Movement Disorders; Neuroendocrine Tumors; Parkinsonian Disorders; Positron-Emission Tomography; Putamen; Radiopharmaceuticals | 2007 |
8 trial(s) available for fluorodopa f 18 and Brain Neoplasms
Article | Year |
---|---|
Initial results of a phase II trial of
Topics: Adult; Brain Neoplasms; Dihydroxyphenylalanine; Glioma; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Re-Irradiation | 2022 |
Initial Results of a Phase 2 Trial of
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Immunological; Bevacizumab; Brain Neoplasms; Chemotherapy, Adjuvant; Cognition; Confidence Intervals; Dihydroxyphenylalanine; Dose Fractionation, Radiation; Female; Glioblastoma; Humans; Kaplan-Meier Estimate; Male; Methylation; Middle Aged; O(6)-Methylguanine-DNA Methyltransferase; Positron-Emission Tomography; Progression-Free Survival; Prospective Studies; Quality of Life; Radiopharmaceuticals; Radiotherapy, Image-Guided; Temozolomide; Young Adult | 2021 |
Prospective trial evaluating the sensitivity and specificity of 3,4-dihydroxy-6-[18F]-fluoro-L-phenylalanine (18F-DOPA) PET and MRI in patients with recurrent gliomas.
Topics: Adolescent; Adult; Brain; Brain Neoplasms; Contrast Media; Dihydroxyphenylalanine; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Salvage Therapy; Sensitivity and Specificity; Young Adult | 2018 |
18F-FDOPA PET/CT for detection of recurrence in patients with glioma: prospective comparison with 18F-FDG PET/CT.
Topics: Adolescent; Adult; Brain Neoplasms; Child; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Recurrence; Reference Standards; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2013 |
Prospective comparison of (99m)Tc-GH SPECT/CT and (18)F-FDOPA PET/CT for detection of recurrent glioma: a pilot study.
Topics: Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Male; Multimodal Imaging; Organotechnetium Compounds; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Recurrence; Sugar Acids; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2014 |
Factors affecting ¹⁸F FDOPA standardized uptake value in patients with primary brain tumors after treatment.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Brain Neoplasms; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult | 2015 |
Brain tumour imaging with PET: a comparison between [18F]fluorodopa and [11C]methionine.
Topics: Adult; Aged; Brain Neoplasms; Dihydroxyphenylalanine; Female; Humans; Male; Methionine; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy.
Topics: Adult; Aged; Brain Neoplasms; California; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2006 |
42 other study(ies) available for fluorodopa f 18 and Brain Neoplasms
Article | Year |
---|---|
Diagnostic value of fusion of metabolic and structural images for stereotactic biopsy of brain tumors without enhancement after contrast medium injection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Brain Neoplasms; Child; Contrast Media; Dihydroxyphenylalanine; Female; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Robotics; Sensitivity and Specificity; Stereotaxic Techniques; Young Adult | 2019 |
18F-FDOPA PET/CT Findings in a Patient With Primary Cerebral Amyloidoma.
Topics: Aged; Amyloidosis; Brain Neoplasms; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Glioma; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2020 |
Metabolic Evolution of Brain Metastasis After Stereotactic Radiosurgery: Mismatch Between F-DOPA and FDG PET.
Topics: Brain Neoplasms; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Radiation-Induced; Positron-Emission Tomography; Radiosurgery | 2020 |
Prediction of MGMT Status for Glioblastoma Patients Using Radiomics Feature Extraction From
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Brain Neoplasms; Dihydroxyphenylalanine; DNA Modification Methylases; DNA Repair Enzymes; Female; Glioblastoma; Humans; Machine Learning; Male; Methylation; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Suppressor Proteins; Young Adult | 2020 |
Photopenic Defects in Gliomas With Amino-Acid PET and Relative Prognostic Value: A Multicentric 11C-Methionine and 18F-FDOPA PET Experience.
Topics: Adult; Aged; Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Male; Methionine; Middle Aged; Positron-Emission Tomography; Progression-Free Survival | 2021 |
Maximum Uptake and Hypermetabolic Volume of 18F-FDOPA PET Estimate Molecular Status and Overall Survival in Low-Grade Gliomas: A PET and MRI Study.
Topics: Adult; Biological Transport; Brain Neoplasms; Diffusion Magnetic Resonance Imaging; Dihydroxyphenylalanine; Female; Glioma; Humans; Isocitrate Dehydrogenase; Male; Middle Aged; Mutation; Positron-Emission Tomography; Retrospective Studies; ROC Curve | 2020 |
Illustration of the Added Value of 18F-DOPA PET to Multimodal MRI to Distinguish Low- and High-Grade Gliomas.
Topics: Adult; Brain Neoplasms; Dihydroxyphenylalanine; Glioma; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Grading; Positron-Emission Tomography | 2021 |
Focal 18F-DOPA Uptake in Brain Parenchyma Surrounding Developmental Venous Anomalies.
Topics: Biological Transport; Brain; Brain Neoplasms; Dihydroxyphenylalanine; Female; Humans; Middle Aged; Parenchymal Tissue; Positron-Emission Tomography; Veins | 2018 |
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Dihydroxyphenylalanine; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Grading; Positron Emission Tomography Computed Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Temozolomide; Tumor Burden | 2018 |
Seizure-Induced Increased 18F-DOPA Uptake in a Child With Diffuse Astrocytoma and Transient Brain MRI Abnormalities Related to Status Epilepticus.
Topics: Astrocytoma; Brain; Brain Neoplasms; Child, Preschool; Dihydroxyphenylalanine; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Status Epilepticus | 2018 |
Topics: Biological Transport; Brain Neoplasms; Chromosome Deletion; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Dihydroxyphenylalanine; Female; Glioma; Humans; Isocitrate Dehydrogenase; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Survival Analysis | 2019 |
Overall survival and progression-free survival in patients with primary brain tumors after treatment: is the outcome of [
Topics: Adult; Brain Neoplasms; Cohort Studies; Dihydroxyphenylalanine; Female; Humans; Male; Positron Emission Tomography Computed Tomography; Progression-Free Survival; Retrospective Studies; ROC Curve | 2019 |
Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study.
Topics: Adult; Aged; Brain Neoplasms; Dihydroxyphenylalanine; Female; Follow-Up Studies; Glioma; Humans; Immunoenzyme Techniques; Male; Middle Aged; Neoplasm Grading; Neurosurgical Procedures; Pilot Projects; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Surgery, Computer-Assisted; Tissue Distribution; Young Adult | 2013 |
Comparative diagnostic accuracy of contrast-enhanced MRI and (18)F-FDOPA PET-CT in recurrent glioma.
Topics: Adult; Brain Neoplasms; Contrast Media; Dihydroxyphenylalanine; Female; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Recurrence; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.
Topics: Adult; Aged; Astrocytoma; Brain Neoplasms; Contrast Media; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Gadolinium; Glioblastoma; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Observer Variation; Oligodendroglioma; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Sensitivity and Specificity; Tumor Burden; Young Adult | 2013 |
(18)F-FDOPA PET for differentiating recurrent or progressive brain metastatic tumors from late or delayed radiation injury after radiation treatment.
Topics: Adult; Aged; Brain Neoplasms; Diagnosis, Differential; Dihydroxyphenylalanine; Disease Progression; Female; Fluorine Radioisotopes; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiation Injuries; Radiotherapy; Recurrence; Sensitivity and Specificity; Young Adult | 2014 |
Can (18)F-FDOPA PET/CT predict survival in patients with suspected recurrent glioma? A prospective study.
Topics: Adolescent; Adult; Brain Neoplasms; Child; Dihydroxyphenylalanine; Female; Glioma; Humans; India; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prevalence; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2014 |
Intra-individual comparison of ¹⁸F-FET and ¹⁸F-DOPA in PET imaging of recurrent brain tumors.
Topics: Astrocytoma; Brain Neoplasms; Dihydroxyphenylalanine; Glioblastoma; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Tyrosine | 2014 |
¹⁸F-FLT and ¹⁸F-FDOPA PET kinetics in recurrent brain tumors.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Brain Neoplasms; Camptothecin; Data Interpretation, Statistical; Dideoxynucleosides; Dihydroxyphenylalanine; Female; Glioma; Humans; Irinotecan; Kinetics; Male; Middle Aged; Models, Biological; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Tissue Distribution | 2014 |
Value of 18F-3,4-dihydroxyphenylalanine PET/MR image fusion in pediatric supratentorial infiltrative astrocytomas: a prospective pilot study.
Topics: Adolescent; Astrocytoma; Biomarkers; Brain; Brain Neoplasms; Child; Dihydroxyphenylalanine; Disease Progression; Disease-Free Survival; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Pilot Projects; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Treatment Outcome | 2014 |
Treatment response evaluation using 18F-FDOPA PET in patients with recurrent malignant glioma on bevacizumab therapy.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Treatment Outcome; Tumor Burden | 2014 |
¹⁸F-fluorodopa positron-emission tomography: an emerging imaging modality for patients with brain metastases.
Topics: Biopsy; Brain Neoplasms; Dihydroxyphenylalanine; Disease Progression; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiation Injuries | 2014 |
Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients.
Topics: Adult; Aged; Aged, 80 and over; Amino Acids; Basal Ganglia; Biopsy; Brain; Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Logistic Models; Male; Middle Aged; Prospective Studies; Radionuclide Imaging; Recurrence; Tyrosine | 2014 |
Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Multimodal Imaging; Necrosis; Positron-Emission Tomography; Postoperative Period; Radiation Injuries; Radiopharmaceuticals; Radiosurgery; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Relationship Between [18F]FDOPA PET Uptake, Apparent Diffusion Coefficient (ADC), and Proliferation Rate in Recurrent Malignant Gliomas.
Topics: Adult; Aged; Brain Neoplasms; Cell Proliferation; Contrast Media; Diffusion; Dihydroxyphenylalanine; Female; Glioma; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Inflammation; Ki-67 Antigen; Magnetic Resonance Imaging; Male; Middle Aged; Mitosis; Mitotic Index; Neoplasm Recurrence, Local; Positron-Emission Tomography; Retrospective Studies; Young Adult | 2015 |
Volumetric assessment of recurrent or progressive gliomas: comparison between F-DOPA PET and perfusion-weighted MRI.
Topics: Adult; Aged; Brain Neoplasms; Cone-Beam Computed Tomography; Dihydroxyphenylalanine; Female; Glioma; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Late Persistent Increased Putaminal 18F-DOPA Uptake Following Ipsilateral Frontal Resection: Evidence for Corticostriatal Synaptic Plasticity?
Topics: Adolescent; Brain Neoplasms; Dihydroxyphenylalanine; Glioma; Humans; Male; Neuronal Plasticity; Putamen; Radionuclide Imaging; Radiopharmaceuticals | 2015 |
Correlation of SUV-Derived Indices With Tumoral Aggressiveness of Gliomas in Static 18F-FDOPA PET: Use in Clinical Practice.
Topics: Adult; Aged; Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Weak uptake of 123I-MIBG and 18F-FDOPA contrasting with high 18F-FDG uptake in stage I neuroblastoma.
Topics: 3-Iodobenzylguanidine; Brain Neoplasms; Child; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Ability of (18)F-DOPA PET/CT and fused (18)F-DOPA PET/MRI to assess striatal involvement in paediatric glioma.
Topics: Adolescent; Brain Neoplasms; Child; Child, Preschool; Dihydroxyphenylalanine; False Negative Reactions; False Positive Reactions; Female; Glioma; Humans; Infant; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neostriatum; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2016 |
Multiparametric evaluation of low grade gliomas at follow-up: comparison between diffusion and perfusion MR with (18)F-FDOPA PET.
Topics: Adult; Aged; Brain Neoplasms; Diffusion Magnetic Resonance Imaging; Dihydroxyphenylalanine; Female; Follow-Up Studies; Glioma; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2016 |
FDOPA PET-CT of Nonenhancing Brain Tumors.
Topics: Adult; Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2017 |
IDH mutation is paradoxically associated with higher
Topics: Adult; Biological Transport; Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Isocitrate Dehydrogenase; Male; Middle Aged; Mutation; Neoplasm Grading; Positron-Emission Tomography; Retrospective Studies | 2017 |
18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience.
Topics: Adult; Aged; Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique | 2009 |
Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas.
Topics: Adolescent; Adult; Brain Neoplasms; Child; Child, Preschool; Dideoxynucleosides; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Young Adult | 2009 |
Joint factor and kinetic analysis of dynamic FDOPA PET scans of brain cancer patients.
Topics: Algorithms; Brain Neoplasms; Computer Simulation; Dihydroxyphenylalanine; Factor Analysis, Statistical; Glioblastoma; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Kinetics; Metabolic Clearance Rate; Models, Biological; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2010 |
Impact of 3,4-dihydroxy-6-18F-fluoro-L-phenylalanine PET/CT on managing patients with brain tumors: the referring physician's perspective.
Topics: Adult; Aged; Aged, 80 and over; Astrocytoma; Brain Neoplasms; Dihydroxyphenylalanine; Female; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Logistic Models; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Oligodendroglioma; Patient Care Management; Physicians; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Surveys and Questionnaires; Tomography, X-Ray Computed; Young Adult | 2012 |
The role of LAT1 in (18)F-DOPA uptake in malignant gliomas.
Topics: Animals; Biological Transport; Blotting, Western; Brain Neoplasms; Dihydroxyphenylalanine; Fluorescent Antibody Technique; Fluorine Radioisotopes; Glioma; Humans; Immunoenzyme Techniques; Large Neutral Amino Acid-Transporter 1; Mice; Neoplasm Grading; Positron-Emission Tomography; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Tumor Cells, Cultured | 2013 |
Hypofractionated stereotactic radiotherapy and continuous low-dose temozolomide in patients with recurrent or progressive malignant gliomas.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Dihydroxyphenylalanine; Disease-Free Survival; Female; Follow-Up Studies; Glioma; Humans; Karnofsky Performance Status; Male; Middle Aged; Radiosurgery; Retrospective Studies; Temozolomide | 2013 |
Evaluation of quantitative criteria for glioma grading with static and dynamic 18F-FDopa PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Invasiveness; Positron-Emission Tomography; Time Factors; Tomography, X-Ray Computed; Young Adult | 2013 |
18F-FDOPA kinetics in brain tumors.
Topics: Adult; Aged; Brain; Brain Neoplasms; Computer Simulation; Dihydroxyphenylalanine; Female; Humans; Image Interpretation, Computer-Assisted; Kinetics; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Radionuclide Imaging; Radiopharmaceuticals | 2007 |
F-Dopa as an amino acid tracer to detect brain tumors.
Topics: Brain; Brain Neoplasms; Deoxyglucose; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Magnetic Resonance Imaging; Methionine; Middle Aged; Oxygen Radioisotopes; Tomography, Emission-Computed; Water | 1996 |